Jyothy Labs

Jyothy Labs consolidated profit jumps 77% to Rs 67.39 cr in Dec quarter

FMCG firm Jyothy Labs Ltd has posted a 77.25 per cent jump in its consolidated net profit at Rs 67.39 crore in the third quarter ended December 31, 2022. The company had posted a consolidated net profit of Rs 38.02 crore in the same period last fiscal, it said in a regulatory filing. Consolidated revenue from operations was at Rs 612.67 crore during the quarter under review as compared to Rs 539.03 crore in the year-ago period, it added. "The business has been resilient in spite of high commodity inflation impacting the consumption across categories. We have been focussed only on execution to drive higher operating revenues and manage margins in the inflationary environment," it said. The company said it has focussed on a strategy to build scale and gain market share backed by enhanced distribution, including reaching out to newer geographies, increase brand visibility and product innovation initiatives. "We continue to drive execution-led growth to build scale. This will deliver

Jyothy Labs Q3 net profit jumps 77.25% to Rs 674 crore, revenue rises

FMCG firm Jyothy Labs Ltd on Wednesday reported a 77.25 per cent jump in its consolidated net profit at Rs 673.9 crore in the third quarter ended December 31, 2022. The company had posted a consolidated net profit of Rs 380.2 crore in the same period last fiscal, it said in a regulatory filing. Consolidated revenue from operations were at Rs 6,126.7 crore during the quarter under review as compared to Rs 5,390.3 crore in the year-ago period, it added. "The business has been resilient in spite of high commodity inflation impacting the consumption across categories. We have been focussed only on execution to drive higher operating revenues and manage margins in the inflationary environment," it said. The company said it has focussed on a strategy to build scale and gain market share backed by enhanced distribution, including reaching out to newer geographies, increase brand visibility and product innovation initiatives. "We continue to drive execution-led growth to build scale. This

Jyothy Labs rallies 9%, hits 4-year high in weak market

Notwithstanding the lockdowns due to the second wave of Covid-19 pandemic, the FMCG sector grew by 36.9 per cent in the April-June quarter of 2021.

Jyothy Labs Q1 net profits up by 18.7% to Rs 47.73 cr; sales up 13.7%

Home-grown FMCG firm Jyothy Labs on Monday reported an 18.73 per cent rise in its consolidated net profit at Rs 47.73 crore in the first quarter ended June 30, 2022

Jyothy Labs Q1 profit down 20% at Rs 40.20 crore on high input cost

Homegrown FMCG firm Jyothy Labs on Thursday reported 19.61 per cent decline in consolidated net profit at Rs 40.20 crore for June quarter 2021-22 on account of increase in input cost

Soap manufacturers keep off price hikes for now amid coronavirus spread

Jyothy Labs' Managing Director MR Jyothy said better hygiene habits were the need of the hour

Daughter M R Jyothy steps out of the shadows to become MD at Jyothy Labs

Independent director R Lakshminarayanan will take over as chairman of the board

Home insecticides business takes sheen off Jyothy Labs' Q4

Weak show of the household insecticides business (under thebrand name Maxo), which forms about a fourth of Jyothy Laboratories' (JyothyLabs') revenue, pulled down overall growth in the March quarter (Q4).Consequently, the company's consolidated revenue grew 4.2 per cent year-on-year(y-o-y) to ~446 crore, missing the Bloomberg consensus estimate of ~478 crore. While peer Godrej Consumer Products (GCPL), too, witnessedsome pressure on its household insecticides revenues in Q4, this business grewfour per cent; but for Jyothy Labs, the household insecticides' revenues fellsix per cent y-o-y in Q4, indicating it could have lost market share, unlikeGCPL which maintained its leadership position. While the company believeshousehold insecticides could improve in case of a normal monsoon, the Streetwill keep a close watch on it given the competitive intensity and its highcontribution to Jyothy Labs' top line.Other than the flattish growth in the smaller segment oflaundry services, Jyothy Labs'

Jyothy Labs: Note ban, cost pressures pull down Q3 show

Weaker margins and slower revenue growth could lead to earnings downgrade

Jyothy Laboratories' Q2 net profit up 61%

Net sales of jumped by a marginal 6.64% to Rs 433.49 crore as against Rs 406.50 crore in same quarter

Jyothy Lab, Biocon, Delta Corp, Accelya Kale hit record highs

KPR Mill, Vakrangee, Aegis Logistics, Bodal Chemicals, IG Petro, Gujarat Alkalies, RPG Life and Surya Roshni too hit their respective record highs on BSE.

Jyothy Labs' Q1 net rises 78% to Rs 46 cr

Net sales rise 9% at Rs 440 cr